BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24308355)

  • 1. Public-private partnerships to revitalize psychiatric drug discovery.
    Brady LS; Potter WZ
    Expert Opin Drug Discov; 2014 Jan; 9(1):1-8. PubMed ID: 24308355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging crowdsourcing to facilitate the discovery of new medicines.
    Norman TC; Bountra C; Edwards AM; Yamamoto KR; Friend SH
    Sci Transl Med; 2011 Jun; 3(88):88mr1. PubMed ID: 21697527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A zebra or a painted horse? Are hospital PPPs infrastructure partnerships with stripes or a separate species?
    Montagu D; Harding A
    World Hosp Health Serv; 2012; 48(2):15-9. PubMed ID: 22913125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings of the 2013 CINP summit: innovative partnerships to accelerate CNS drug discovery for improved patient care.
    Phillips AG; Hongaard-Andersen P; Moscicki RA; Sahakian B; Quirion R; Krishnan KR; Race T
    Int J Neuropsychopharmacol; 2014 Dec; 18(3):. PubMed ID: 25542690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public-private partnerships for health--what does the evidence say?
    Thomason J; Rodney A
    P N G Med J; 2009; 52(3-4):166-78. PubMed ID: 21877579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public-private partnership: from there to here.
    Croft SL
    Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S9-14. PubMed ID: 16087204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public-Private Partnerships: Compound and Data Sharing in Drug Discovery and Development.
    Davis AM; Engkvist O; Fairclough RJ; Feierberg I; Freeman A; Iyer P
    SLAS Discov; 2021 Jun; 26(5):604-619. PubMed ID: 33586501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming the current deadlock in antibiotic research.
    Schäberle TF; Hack IM
    Trends Microbiol; 2014 Apr; 22(4):165-7. PubMed ID: 24698433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How shall we examine and learn about public-private partnerships (PPPs) in the health sector? Realist evaluation of PPPs in Hong Kong.
    Wong EL; Yeoh EK; Chau PY; Yam CH; Cheung AW; Fung H
    Soc Sci Med; 2015 Dec; 147():261-9. PubMed ID: 26605970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four disruptive strategies for removing drug discovery bottlenecks.
    Ekins S; Waller CL; Bradley MP; Clark AM; Williams AJ
    Drug Discov Today; 2013 Mar; 18(5-6):265-71. PubMed ID: 23098820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public-Private Partnerships and Undernutrition: Examples and Future Prospects.
    Hoddinott J; Gillespie S; Yosef S
    World Rev Nutr Diet; 2016; 115():233-8. PubMed ID: 27198661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public-private partnerships: an overview.
    Widdus R
    Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S1-8. PubMed ID: 16085172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public-Private Partnerships in the health sector: the Danish experience.
    Vrangbaek K
    Health Econ Policy Law; 2008 Apr; 3(Pt 2):141-63. PubMed ID: 18634625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery.
    Thomas CE; Will Y
    Expert Opin Drug Discov; 2012 Feb; 7(2):109-22. PubMed ID: 22468913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of public-private partnerships in addressing the biomedical innovation challenge.
    Said M; Zerhouni E
    Nat Rev Drug Discov; 2014 Nov; 13(11):789-90. PubMed ID: 25359362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing Public-Private Partnerships in Plant Pathology Extension: Case Studies and Opportunities in the United States.
    Markell SG; Tylka GL; Anderson EJ; van Esse HP
    Annu Rev Phytopathol; 2020 Aug; 58():161-180. PubMed ID: 32543952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public-Private Partnerships in Lead Discovery: Overview and Case Studies.
    Gottwald M; Becker A; Bahr I; Mueller-Fahrnow A
    Arch Pharm (Weinheim); 2016 Sep; 349(9):692-7. PubMed ID: 27335205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug discovery and beyond: the role of public-private partnerships in improving access to new malaria medicines.
    Nwaka S
    Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S20-9. PubMed ID: 16085175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs for children and adolescents with cancer: the need for novel development pathways.
    Vassal G; Zwaan CM; Ashley D; Le Deley MC; Hargrave D; Blanc P; Adamson PC
    Lancet Oncol; 2013 Mar; 14(3):e117-24. PubMed ID: 23434337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.